At Medmeme, we help pharma companies quantify and analyze the vast and ever-expanding world of medical science — and empower their medical affairs departments to use those insights to make strategic
data-based decisions that generate
Medmeme provides web-based solutions that analyze data across the entire medical continuum, providing a connected picture on published scientific literature, meetings
In Q4 2018, Medmeme will become Pharmaspectra, a new company with a broader mission and product set.
OUR DATA PROCESS
Medical data is constantly being generated from disparate sources all over the world. Tracking the development and impact of any single drug in the scientific literature is a highly challenging process, not unlike assembling a machine from various components scattered around a workshop.
Medmeme Delta centralizes, structures and sequences all relevant data points in the lifecycle of a drug, organizing this information into a medical continuum that replaces educated guesses with concrete, actionable intelligence.